Vaccination against infectious diseases has changed the future of the human species,
saving millions of lives every year, both children and adults, and providing major benefits to …

Simple Summary The main way to overcome the COVID-19 pandemic is mass vaccination of
the public. However, the public's vaccine hesitancy toward the available vaccines is a big …

The fight against infectious diseases calls for the development of safe and effective vaccines
that generate long-lasting protective immunity. In a few situations, vaccine-mediated immune …

Given our global interconnectedness, the COVID-19 pandemic highlights the urgency of
building a global system that can support both routine and pandemic/epidemic adult …

In December 2020, the first coronavirus disease 2019 (COVID-19) vaccine was authorized
in the European Union. This study aimed to assess the changes in attitudes towards the …

Summary Background Lower respiratory infections (LRIs) are a major global contributor to
morbidity and mortality. In 2020–21, non-pharmaceutical interventions associated with the …

Background Influenza causes significant morbidity and mortality and stresses hospital
resources during periods of increased circulation. We evaluated the effectiveness of the …

Introduction People with substance use disorders are considered a priority group for SARS‐
CoV‐2 vaccination as they are at elevated risk of COVID‐19 and its severe complications …

Objectives To provide a new value-based immunization approach collating the available
scientific evidence on the topic. Methods Four value pillars (personal, allocative, technical …

Background and purpose Health risks associated with SARS‐CoV‐2 infection are
undisputed. Moreover, the capability of vaccination to prevent symptomatic, severe, and fatal …